EPM for the Pharmaceutical Industry
Helping pharma companies connect R&D, commercial and supply — with brand-, country- and SKU-level planning on Oracle EPM.
Pharma performance is driven by pipeline progress, brand momentum, gross-to-net, supply economics and regulatory compliance across R&D, commercial, supply and finance.
Cloudmaven delivers integrated pharma EPM solutions covering the full lifecycle from pipeline planning to brand P&L.
Advantages for the Pharmaceutical Industry
Key Challenges
- Long R&D pipelines with high uncertainty and significant capital exposure
- Complex global supply chains under strict GxP and regulatory compliance
- Patent cliffs, generics erosion and lifecycle management of products
- Country-by-country pricing, reimbursement and market-access dynamics
Our Approach
- Driver-based planning by brand, country, channel and SKU
- Gross-to-net and tender modeling integrated into the corporate plan
- Risk-adjusted R&D pipeline planning with probability-weighted NPVs
- Supply, inventory and cost-of-goods modeling linked to demand forecasts
Core KPIs
- Sales by Brand & Country
- Gross-to-Net %
- R&D Spend vs. Pipeline
- Field Force Productivity
- Operating Margin %
Let’s talk pharma EPM. Connect R&D, commercial and supply into one trusted platform.
Let our experts advise you without obligation
